Lv01
0 积分 2025-03-18 加入
OA01.03 Benmelstobart with Anlotinib plus Chemotherapy as First-line Therapy for ES-SCLC: A Randomized, Double-blind, Phase III Trial
1小时前
待确认
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan
1小时前
已完结
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
1小时前
已完结
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
1小时前
已完结
皖公网安备34019202002308
